U
OPTR

UBS’s OPTIMER PHARMACEUTICALS, INC. COM STK OPTR Stock Holding History

UBS’s Portfolio OPTR Stock Details OPTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-4,600
Closed -$58K – 11346
2013
Q3 		$58K Sell
4,600
-66,100
-93% -$876K ﹤0.01% 6688
2013
Q2 		$1.02M Buy
+70,700
New +$1.03M ﹤0.01% 3311

UBS's OPTR Position: Q4 2013 in Review

UBS sold out of OPTIMER PHARMACEUTICALS, INC. COM STK (OPTR) in Q4 2013, closing a stake of 36,897 shares — an estimated $464K sold.

UBS first reported a position in OPTR in Q2 2013 and held it in 2 quarters. The position peaked at $464K in Q3 2013. 0 funds tracked by Wall St. Rank hold OPTR as of Q4 2013.

  • UBS reported no remaining OPTIMER PHARMACEUTICALS, INC. COM STK position as of Q4 2013 after selling out during the quarter.
  • UBS sold 36,897 OPTIMER PHARMACEUTICALS, INC. COM STK shares in Q4 2013, an estimated $464K.
  • UBS first reported a position in OPTIMER PHARMACEUTICALS, INC. COM STK in Q2 2013 and held it in 2 quarters.
  • UBS's OPTIMER PHARMACEUTICALS, INC. COM STK position peaked at $464K in Q3 2013.
  • 0 funds tracked by Wall St. Rank held OPTIMER PHARMACEUTICALS, INC. COM STK as of Q4 2013.

Based on UBS's 13F filing for Q4 2013, filed 14 Feb 2014.